Tracing the origins: COVID-19 is not naturally-occurring – WION

According to the Wall Street Journal, China has now backed away from its claim that the COVID-19 outbreak originated in the Wuhan Seafood Market through transmission from animals to humans.

Since the onset of the pandemic, China has flooded the scientific literature with that claim, but now has been forced to admit that it is false.

The search for the truth has been hampered by the global media, which have been eagerly and uncritically regurgitating the Chinese Communist Partys narrative that COVID-19 is naturally-occurring.

That is, while circulating in animals, a bat coronavirus mutated, perhaps through another intermediate animal host, acquiring the ability to infect humans, presumably workers in the market.

That argument was never scientifically viable.

It was already known by the end of January 2020, that the initial patients hospitalized between December 1-10, 2019 had not visited the market and bats were not sold there.

The environmental samples taken from the Wuhan Seafood Market were genetically identical to human COVID-19, largely ruling out an intermediate host animal.

More importantly, the same study found that, in a side-by-side comparison of the evolutionary dynamics between COVID-19 and the coronavirus that caused the 2003 SARS-CoV pandemic, the early COVID-19 samples were already pre-adapted for human transmission to an extent similar to late epidemic SARS-CoV.

That is, there was no evidence of a naturally-occurring transmission from animals to humans via the Wuhan Seafood Market and no naturally-occurring human adaptation during the course of the outbreak.

COVID-19 was already well-adapted for human infection. That notion is scientifically supported by a structural analysis of COVID-19.

China claims COVID-19 originated in bats, which is probably partially correct.

The viral backbone of COVID-19 is likely from bats, but there is conclusive scientific evidence that COVID-19s receptor-binding domain within the spike protein is structurally closest to that of pangolins (scaly anteaters) and that its presence in COVID-19 could not have resulted from a natural recombinant event or convergent evolution.

A pangolin-like receptor binding domain within a spike protein was probably inserted using the same bioengineering techniques used in a study published by Ralph Baric from the University of North Carolina and Zheng-Li Shi, the bat woman from the Wuhan Institute of Virology.

That study described the insertion of the spike protein from a newly isolated bat coronavirus (SHC014) onto the backbone from SARS-CoV, the coronavirus responsible for the 2003 pandemic.

In a December 9, 2019 interview, Dr. Peter Daszak, President of the EcoHealth Alliance and a long-time collaborator with the Wuhan Institute of Virology, presumably referring to the Ralph Baric- Zheng-Li Shi experiments, stated you can manipulate them in the lab pretty easily inserting a spike protein into a backbone of another virus.

Furthermore, there is no credible scientific evidence that COVID-19s furin polybasic cleavage site (RRAR) at the S1/S2 junction in the spike protein, a distinctive feature widely known for its ability to enhance pathogenicity and transmissibility and not present in any closely related bat coronavirus, could have evolved naturally.

In contrast, the methods for artificially inserting such cleavage sites are well-established.

In 2017, Chinese scientists Xing-Yi Ge and bat woman Zheng-Li Shi of the Wuhan Institute of Virology found the same furin polybasic cleavage site (RRAR) at the S1/S2 junction in a rat coronavirus.

It was Xing-Yi Ge, in 2020, who identified the furin polybasic cleavage site (RRAR) at the S1/S2 junction in COVID-19.

It was Zheng-Li Shi, who, in February 2020, first reported on the previously unknown bat coronavirus, RaTG13, which has an overall 96.2% structurally similarity to COVID-19, but the receptor-binding domain was significantly different from COVID-19 and RaTG13 did not have a furin polybasic cleavage site.

It seems likely that bat coronavirus RaTG13 or something similar was used as a backbone to which a pangolin-like receptor binding domain within a spike protein was inserted, followed by the addition of a furin polybasic cleavage site.

Further human adaptation could have been achieved by sequential passage through humanized animal models described by Peter Daszak, used in the above-mentioned experiments by Ralph Baric and Zheng-Li Shi and published by Chinese scientists.

Given the overwhelming scientific evidence indicating that it is man-made, the burden of proof is now on China to prove COVID-19 is naturally-occurring.

(Disclaimer: The opinions expressed above are the personal views of the author and do not reflect the views of ZMCL)

More here:
Tracing the origins: COVID-19 is not naturally-occurring - WION

Bilirubin Market Overview With Detailed Analysis, Competitive Landscape, Forecast to 2026| Chongqing Jiangxia Shenghua Zhiyao, AnHui Chem-Right…

LOS ANGELES, United States: QY Research has recently published a report, titled Global Bilirubin Market Research Report 2020-2026. The research report provides an in-depth explanation of the various factors that are likely to drive the market. It discusses the future of the market by studying the historical details. Analysts have studied the ever-changing market dynamics to evaluate their impact on the overall market. In addition, the Bilirubin report also discusses the segments present in the market. Primary and secondary research methodologies have been used to provide the readers with an accurate and precise understanding of the overall Bilirubin market. Analysts have also given readers an unbiased opinion about the direction companies will take during the forecast period.

The research report also includes the global Bilirubin market figures that provide historical data as well as estimated figures. It gives a clear picture of the growth rate of the market during the forecast period. The Bilirubin report aims to give the readers quantifiable data that is collected from verified data. The report attempts to answer all the difficult questions such as market sizes and company strategies.

Download Full PDF Sample Copy of Bilirubin Report with TOC, figure and tables:@https://www.qyresearch.com/sample-form/form/1708985/global-bilirubin-market

The vendor landscape and competitive scenarios of the global Bilirubin market are broadly analyzed to help market players gain competitive advantage over their competitors. Readers are provided with detailed analysis of important competitive trends of the global Bilirubin market. Market players can use the analysis to prepare themselves for any future challenges well in advance. They will also be able to identify opportunities to attain a position of strength in the global Bilirubin market. Furthermore, the analysis will help them to effectively channelize their strategies, strengths, and resources to gain maximum advantage in the global Bilirubin market.

Key Players Mentioned in the Global Bilirubin Market Research Report:

Chongqing Jiangxia Shenghua Zhiyao, AnHui Chem-Right Bioengineering, Pingdingshanshi Huishengyuan Shengwuzhipin, Chongqing Jingkang Biotechnology, Wuhan Yuancheng Gongchuang Technology, Shaanxi Pioneer Biotech, Hubei Prosperity Galaxy Chemical, Zelang Group, Chengdu Tianyuan Natural Product, Maanshan Hui Zhi Biotech, Shaanxi Sciphar Hi-Tech Industry, Xian Bai Chuan Biotechnology, Anhui Tianqi Chemical Engineering, Nanjing Dilger Medical Technology

Global Bilirubin Market Segmentation by Product:90% Bilirubinn95% BilirubinOther Purity

Global Bilirubin Market Segmentation by Application:Artificial BezoarMedicine IndustryOther Application

The report comes out as an accurate and highly detailed resource for gaining significant insights into the growth of different product and application segments of the global Bilirubin market. Each segment covered in the report is exhaustively researched about on the basis of market share, growth potential, drivers, and other crucial factors. The segmental analysis provided in the report will help market players to know when and where to invest in the global Bilirubin market. Moreover, it will help them to identify key growth pockets of the global Bilirubin market.

Key Questions Answered What will be the size and CAGR of the global Bilirubin market in 2025? Which product will gain the highest demand in the global Bilirubin market? Which application could show the best growth in the global Bilirubin market? What will be the nature of the competitive landscape in future? Which players will lead the global Bilirubin market in the coming years? Which region will gain the largest share of the global Bilirubin market?

Request for customization in Report:@https://www.qyresearch.com/customize-request/form/1708985/global-bilirubin-market

Table of Content1 Bilirubin Market Overview1.1 Bilirubin Product Overview1.2 Bilirubin Market Segment by Type1.2.1 90% Bilirubinn1.2.2 95% Bilirubin1.2.3 Other Purity1.3 Global Bilirubin Market Size by Type (2015-2026)1.3.1 Global Bilirubin Market Size Overview by Type (2015-2026)1.3.2 Global Bilirubin Historic Market Size Review by Type (2015-2020)1.3.2.1 Global Bilirubin Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global Bilirubin Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global Bilirubin Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Bilirubin Market Size Forecast by Type (2021-2026)1.3.3.1 Global Bilirubin Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global Bilirubin Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global Bilirubin Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Bilirubin Sales Breakdown by Type (2015-2026)1.4.2 Europe Bilirubin Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Bilirubin Sales Breakdown by Type (2015-2026)1.4.4 Latin America Bilirubin Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Bilirubin Sales Breakdown by Type (2015-2026)1.5 Coronavirus Disease 2019 (Covid-19): Bilirubin Industry Impact1.5.1 How the Covid-19 is Affecting the Bilirubin Industry1.5.1.1 Bilirubin Business Impact Assessment Covid-191.5.1.2 Supply Chain Challenges1.5.1.3 COVID-19s Impact On Crude Oil and Refined Products1.5.2 Market Trends and Bilirubin Potential Opportunities in the COVID-19 Landscape1.5.3 Measures / Proposal against Covid-191.5.3.1 Government Measures to Combat Covid-19 Impact1.5.3.2 Proposal for Bilirubin Players to Combat Covid-19 Impact

2 Global Bilirubin Market Competition by Company2.1 Global Top Players by Bilirubin Sales (2015-2020)2.2 Global Top Players by Bilirubin Revenue (2015-2020)2.3 Global Top Players Bilirubin Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Bilirubin Manufacturing Base Distribution, Sales Area, Product Type2.5 Bilirubin Market Competitive Situation and Trends2.5.1 Bilirubin Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Bilirubin Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bilirubin as of 2019)2.7 Date of Key Manufacturers Enter into Bilirubin Market2.8 Key Manufacturers Bilirubin Product Offered2.9 Mergers & Acquisitions, Expansion

3 Global Bilirubin Status and Outlook by Region (2015-2026)3.1 Global Bilirubin Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Bilirubin Market Size Market Share by Region (2015-2020)3.2.1 Global Bilirubin Sales Market Share by Region (2015-2020)3.2.2 Global Bilirubin Revenue Market Share by Region (2015-2020)3.2.3 Global Bilirubin Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Bilirubin Market Size Market Share by Region (2021-2026)3.3.1 Global Bilirubin Sales Market Share by Region (2021-2026)3.3.2 Global Bilirubin Revenue Market Share by Region (2021-2026)3.3.3 Global Bilirubin Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Bilirubin Market Size YoY Growth (2015-2026)3.4.1 North America Bilirubin Revenue YoY Growth (2015-2026)3.4.2 North America Bilirubin Sales YoY Growth (2015-2026)3.5 Asia-Pacific Bilirubin Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Bilirubin Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Bilirubin Sales YoY Growth (2015-2026)3.6 Europe Bilirubin Market Size YoY Growth (2015-2026)3.6.1 Europe Bilirubin Revenue YoY Growth (2015-2026)3.6.2 Europe Bilirubin Sales YoY Growth (2015-2026)3.7 Latin America Bilirubin Market Size YoY Growth (2015-2026)3.7.1 Latin America Bilirubin Revenue YoY Growth (2015-2026)3.7.2 Latin America Bilirubin Sales YoY Growth (2015-2026)3.8 Middle East and Africa Bilirubin Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Bilirubin Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Bilirubin Sales YoY Growth (2015-2026)

4 Global Bilirubin by Application4.1 Bilirubin Segment by Application4.1.1 Artificial Bezoar4.1.2 Medicine Industry4.1.3 Other Application4.2 Global Bilirubin Sales by Application: 2015 VS 2020 VS 20264.3 Global Bilirubin Historic Sales by Application (2015-2020)4.4 Global Bilirubin Forecasted Sales by Application (2021-2026)4.5 Key Regions Bilirubin Market Size by Application4.5.1 North America Bilirubin by Application4.5.2 Europe Bilirubin by Application4.5.3 Asia-Pacific Bilirubin by Application4.5.4 Latin America Bilirubin by Application4.5.5 Middle East and Africa Bilirubin by Application5 North America Bilirubin Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Bilirubin Sales Market Share by Country (2015-2020)5.1.2 North America Bilirubin Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Bilirubin Sales Market Share by Country (2021-2026)5.2.2 North America Bilirubin Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Bilirubin Market Size YoY Growth (2015-2026)5.3.2 Canada Bilirubin Market Size YoY Growth (2015-2026)6 Europe Bilirubin Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Bilirubin Sales Market Share by Country (2015-2020)6.1.2 Europe Bilirubin Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Bilirubin Sales Market Share by Country (2021-2026)6.2.2 Europe Bilirubin Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Bilirubin Market Size YoY Growth (2015-2026)6.3.2 France Bilirubin Market Size YoY Growth (2015-2026)6.3.3 U.K. Bilirubin Market Size YoY Growth (2015-2026)6.3.4 Italy Bilirubin Market Size YoY Growth (2015-2026)6.3.5 Russia Bilirubin Market Size YoY Growth (2015-2026)7 Asia-Pacific Bilirubin Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Bilirubin Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Bilirubin Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Bilirubin Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Bilirubin Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Bilirubin Market Size YoY Growth (2015-2026)7.3.2 Japan Bilirubin Market Size YoY Growth (2015-2026)7.3.3 South Korea Bilirubin Market Size YoY Growth (2015-2026)7.3.4 India Bilirubin Market Size YoY Growth (2015-2026)7.3.5 Australia Bilirubin Market Size YoY Growth (2015-2026)7.3.6 Taiwan Bilirubin Market Size YoY Growth (2015-2026)7.3.7 Indonesia Bilirubin Market Size YoY Growth (2015-2026)7.3.8 Thailand Bilirubin Market Size YoY Growth (2015-2026)7.3.9 Malaysia Bilirubin Market Size YoY Growth (2015-2026)7.3.10 Philippines Bilirubin Market Size YoY Growth (2015-2026)7.3.11 Vietnam Bilirubin Market Size YoY Growth (2015-2026)8 Latin America Bilirubin Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Bilirubin Sales Market Share by Country (2015-2020)8.1.2 Latin America Bilirubin Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Bilirubin Sales Market Share by Country (2021-2026)8.2.2 Latin America Bilirubin Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Bilirubin Market Size YoY Growth (2015-2026)8.3.2 Brazil Bilirubin Market Size YoY Growth (2015-2026)8.3.3 Argentina Bilirubin Market Size YoY Growth (2015-2026)9 Middle East and Africa Bilirubin Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Bilirubin Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Bilirubin Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Bilirubin Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Bilirubin Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Bilirubin Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Bilirubin Market Size YoY Growth (2015-2026)9.3.3 UAE Bilirubin Market Size YoY Growth (2015-2026)

10 Company Profiles and Key Figures in Bilirubin Business10.1 Chongqing Jiangxia Shenghua Zhiyao10.1.1 Chongqing Jiangxia Shenghua Zhiyao Corporation Information10.1.2 Chongqing Jiangxia Shenghua Zhiyao Description, Business Overview and Total Revenue10.1.3 Chongqing Jiangxia Shenghua Zhiyao Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.1.4 Chongqing Jiangxia Shenghua Zhiyao Bilirubin Products Offered10.1.5 Chongqing Jiangxia Shenghua Zhiyao Recent Development10.2 AnHui Chem-Right Bioengineering10.2.1 AnHui Chem-Right Bioengineering Corporation Information10.2.2 AnHui Chem-Right Bioengineering Description, Business Overview and Total Revenue10.2.3 AnHui Chem-Right Bioengineering Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.2.4 Chongqing Jiangxia Shenghua Zhiyao Bilirubin Products Offered10.2.5 AnHui Chem-Right Bioengineering Recent Development10.3 Pingdingshanshi Huishengyuan Shengwuzhipin10.3.1 Pingdingshanshi Huishengyuan Shengwuzhipin Corporation Information10.3.2 Pingdingshanshi Huishengyuan Shengwuzhipin Description, Business Overview and Total Revenue10.3.3 Pingdingshanshi Huishengyuan Shengwuzhipin Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.3.4 Pingdingshanshi Huishengyuan Shengwuzhipin Bilirubin Products Offered10.3.5 Pingdingshanshi Huishengyuan Shengwuzhipin Recent Development10.4 Chongqing Jingkang Biotechnology10.4.1 Chongqing Jingkang Biotechnology Corporation Information10.4.2 Chongqing Jingkang Biotechnology Description, Business Overview and Total Revenue10.4.3 Chongqing Jingkang Biotechnology Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.4.4 Chongqing Jingkang Biotechnology Bilirubin Products Offered10.4.5 Chongqing Jingkang Biotechnology Recent Development10.5 Wuhan Yuancheng Gongchuang Technology10.5.1 Wuhan Yuancheng Gongchuang Technology Corporation Information10.5.2 Wuhan Yuancheng Gongchuang Technology Description, Business Overview and Total Revenue10.5.3 Wuhan Yuancheng Gongchuang Technology Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.5.4 Wuhan Yuancheng Gongchuang Technology Bilirubin Products Offered10.5.5 Wuhan Yuancheng Gongchuang Technology Recent Development10.6 Shaanxi Pioneer Biotech10.6.1 Shaanxi Pioneer Biotech Corporation Information10.6.2 Shaanxi Pioneer Biotech Description, Business Overview and Total Revenue10.6.3 Shaanxi Pioneer Biotech Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.6.4 Shaanxi Pioneer Biotech Bilirubin Products Offered10.6.5 Shaanxi Pioneer Biotech Recent Development10.7 Hubei Prosperity Galaxy Chemical10.7.1 Hubei Prosperity Galaxy Chemical Corporation Information10.7.2 Hubei Prosperity Galaxy Chemical Description, Business Overview and Total Revenue10.7.3 Hubei Prosperity Galaxy Chemical Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.7.4 Hubei Prosperity Galaxy Chemical Bilirubin Products Offered10.7.5 Hubei Prosperity Galaxy Chemical Recent Development10.8 Zelang Group10.8.1 Zelang Group Corporation Information10.8.2 Zelang Group Description, Business Overview and Total Revenue10.8.3 Zelang Group Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.8.4 Zelang Group Bilirubin Products Offered10.8.5 Zelang Group Recent Development10.9 Chengdu Tianyuan Natural Product10.9.1 Chengdu Tianyuan Natural Product Corporation Information10.9.2 Chengdu Tianyuan Natural Product Description, Business Overview and Total Revenue10.9.3 Chengdu Tianyuan Natural Product Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.9.4 Chengdu Tianyuan Natural Product Bilirubin Products Offered10.9.5 Chengdu Tianyuan Natural Product Recent Development10.10 Maanshan Hui Zhi Biotech10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Bilirubin Product Category, Application and Specification10.10.3 Maanshan Hui Zhi Biotech Bilirubin Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 Maanshan Hui Zhi Biotech Recent Development10.11 Shaanxi Sciphar Hi-Tech Industry10.11.1 Shaanxi Sciphar Hi-Tech Industry Corporation Information10.11.2 Shaanxi Sciphar Hi-Tech Industry Description, Business Overview and Total Revenue10.11.3 Shaanxi Sciphar Hi-Tech Industry Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.11.4 Shaanxi Sciphar Hi-Tech Industry Bilirubin Products Offered10.11.5 Shaanxi Sciphar Hi-Tech Industry Recent Development10.12 Xian Bai Chuan Biotechnology10.12.1 Xian Bai Chuan Biotechnology Corporation Information10.12.2 Xian Bai Chuan Biotechnology Description, Business Overview and Total Revenue10.12.3 Xian Bai Chuan Biotechnology Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.12.4 Xian Bai Chuan Biotechnology Bilirubin Products Offered10.12.5 Xian Bai Chuan Biotechnology Recent Development10.13 Anhui Tianqi Chemical Engineering10.13.1 Anhui Tianqi Chemical Engineering Corporation Information10.13.2 Anhui Tianqi Chemical Engineering Description, Business Overview and Total Revenue10.13.3 Anhui Tianqi Chemical Engineering Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.13.4 Anhui Tianqi Chemical Engineering Bilirubin Products Offered10.13.5 Anhui Tianqi Chemical Engineering Recent Development10.14 Nanjing Dilger Medical Technology10.14.1 Nanjing Dilger Medical Technology Corporation Information10.14.2 Nanjing Dilger Medical Technology Description, Business Overview and Total Revenue10.14.3 Nanjing Dilger Medical Technology Bilirubin Sales, Revenue and Gross Margin (2015-2020)10.14.4 Nanjing Dilger Medical Technology Bilirubin Products Offered10.14.5 Nanjing Dilger Medical Technology Recent Development

11 Bilirubin Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Bilirubin Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Bilirubin Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis

12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers

13 Research Findings and Conclusion

14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us:We established as a research firm in 2007 and have since grown into a trusted brand amongst many industries. Over the years, we have consistently worked toward delivering high-quality customized solutions for wide range of clients ranging from ICT to healthcare industries. With over 50,000 satisfied clients, spread over 80 countries, we have sincerely strived to deliver the best analytics through exhaustive research methodologies.

More here:
Bilirubin Market Overview With Detailed Analysis, Competitive Landscape, Forecast to 2026| Chongqing Jiangxia Shenghua Zhiyao, AnHui Chem-Right...

Clinical trial of CAR-T technology to treat blood cancer to begin soon – Hindustan Times

A team of researchers from the Indian Institute of Technology-Bombay (IIT-B) and doctors from the Tata Memorial Centre (TMC), Mumbai, will soon start the first clinical trial of indigenously developed CAR-T technology in the country for the treatment of blood cancer.

The central governments National Biopharma Mission (NBM) -Biotechnology Industry Research Assistance Council (BIRAC) has now approved 18.96 crore to the team for conducting a first-in-human phase-1/2 clinical trial of the CAR-T cells. The novel CAR-T cells will act are drugs that were indigenously developed at IIT Bombay by Rahul Purwar, a professor from the Bioscience and Bioengineering (BSBE) department. The design, development, and extensive pre-clinical testing was carried out in a laboratory with clinical inputs from Dr Gaurav Narula, professor of Pediatric Oncology and Health Sciences, and his team from TMC. The team has filed for national and international patents for the product.

While the CAR-T cell technology is currently in use in developed nations with an intent to cure certain types of blood cancers, the technology is still unavailable in India. One of the major reasons for its unavailability in India is that the drug is exorbitantly expensive. Pharmaceutical companies dont see a market for such expensive treatments in India, said Purwar. Two CAR-T products approved by the United States of America are Kymriah and Yescarta. However, the drugs could cost Rs5 crore per patient and could go up to 8 crore including hospital expenses.

The IIT Bombay and TMC team are working on reducing this cost. A large part of the manufacturing cost goes towards skilled labour. While we are at the initial stage, we will try to bring the costs significantly down, said Purwar. The drug is aimed at treating leukaemia and lymphoma. The BIRAC, in its statement, said that with the success of the trial, the drug will benefit cancer patients, who currently are forced to opt for palliative care.

With the grant in place, clinical trials of the novel CAR-T cells will commence at TMC. Current treatment strategies, such as chemotherapy, are aimed at promoting life by a few months or years. They are not intended to cure cancer. The CAR-T cells have been fairly successful in this matter in some developed nations, said Purwar. Unlike chemotherapy, this drug is administered only once to the patient.

Dr Narula said that the clinical trial of the drug will be started in a trial set up where all variables are under control. We have received the grant to start the trial. This is one step in a long process. We will start the trial as soon as the regulators give us a go-ahead, he said. The team is now waiting for approval from the Central Drugs Standard Control Organisation.

Continued here:
Clinical trial of CAR-T technology to treat blood cancer to begin soon - Hindustan Times

Assessing the Fallout From the Coronavirus Pandemic Polyoxin Market 2020: Global Size, Supply-Demand, Product Type and End User Analysis To 2039 -…

The global Polyoxin market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Polyoxin market player in a comprehensive way. Further, the Polyoxin market report emphasizes the adoption pattern of the Polyoxin across various industries.

The Polyoxin market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail.

The report on the Polyoxin market provides a birds eye view of the current proceeding within the Polyoxin market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Polyoxin market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2670577&source=atm

Key market playersMajor competitors identified in this market include Jiangsu Fengyuan Bioengineering, Beijing Green Agrosino, Kaken Pharmaceutical, Nufarm Limited, Arysta LifeScience, Certis, OHP Inc, Cleary Chemical Corp, Hanzhou Dayangchem, Shanxi Lvhai Agrochemicals, etc.

Based on the Region:Asia-Pacific (China, Japan, South Korea, India and ASEAN)North America (US and Canada)Europe (Germany, France, UK and Italy)Rest of World (Latin America, Middle East & Africa)

Based on the Type:Polyoxin BPolyoxin D

Based on the Application:HumanityAnimal

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2670577&source=atm

The Polyoxin market report offers a plethora of insights which include:

The Polyoxin market report answers important questions which include:

The Polyoxin market report considers the following years to predict the market growth:

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2670577&licType=S&source=atm

Why Choose Polyoxin Market Report?

Polyoxin Market Reportfollows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

Continued here:
Assessing the Fallout From the Coronavirus Pandemic Polyoxin Market 2020: Global Size, Supply-Demand, Product Type and End User Analysis To 2039 -...

Feed Additive Nosiheptide Premix Market Analysis, Market Size, In-Depth Insights, Growth and Forecast to 2026| Mitsubishi Company, Zhejiang Esigma…

LOS ANGELES, United States:The comprehensive research and analysis report comes out as an incredible and a must-have resource for global Feed Additive Nosiheptide Premix industry players to gain a competitive edge over their opponents. It includes reliable and verified industry size, CAGR, production, consumption, and sales forecasts for the global Feed Additive Nosiheptide Premix industry. It also provides industry revenue and volume estimates for years up to 2026. Readers of the report can easily become aware of ongoing and future trends, key opportunities, challenges, and growth drivers of the global Feed Additive Nosiheptide Premix industry.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart):https://www.qyresearch.com/sample-form/form/1700480/covid-19-impact-on-global-feed-additive-nosiheptide-premix-market

The report offers highly detailed competitive analysis of the global Feed Additive Nosiheptide Premix industry, where the business and industry growth of leading companies are thoroughly evaluated on the basis of production, product portfolio, recent developments, technology, geographical footprint, and various other factors. The authors of the report have also provided information on future changes in the competitive landscape and the expected nature of competition in the global Feed Additive Nosiheptide Premix industry. This will help players to prepare themselves well for any unforeseen situations in the industry competition and give a tough competition to other players in the global Feed Additive Nosiheptide Premix industry.

Key Players Mentioned in the Global Feed Additive Nosiheptide Premix Market Research Report:Mitsubishi Company, Zhejiang Esigma Animal Health, Anhui Wanbei Pharmaceutical, ZheJiang MingZhu Animal Health Products, Chattha Group, Zhejiang University Sunny Nutrition Technology, Shandong Shengli Bioengineering, Fenghe Bio-Technology, Bornsun Bioengineering

Global Feed Additive Nosiheptide Premix Market by Type:Below 4%, Between(4%-12%)

Global Feed Additive Nosiheptide Premix Market by Application:Livestock, Poultry

The segmentation study provided in the report enables players to take informed decisions when operating in particular segments of the global Feed Additive Nosiheptide Premix industry. It also allows players to plan effective strategies to increase the chances of maximizing their growth in leading segments of the global Feed Additive Nosiheptide Premix industry.

In the regional analysis section, the report offers in-depth analysis of top geographies and their drivers along with accurate forecasts for their growth rate, industry size, and other factors. The report also includes recommendations and suggestions for players to ensure long-term growth in the global Feed Additive Nosiheptide Premix industry.

Questions Answered by the Report:

Request for customization in Report:https://www.qyresearch.com/customize-request/form/1700480/covid-19-impact-on-global-feed-additive-nosiheptide-premix-market

1 Study Coverage1.1 Feed Additive Nosiheptide Premix Product Introduction1.2 Market Segments1.3 Key Feed Additive Nosiheptide Premix Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global Feed Additive Nosiheptide Premix Market Size Growth Rate by Type1.4.2 Below 4%1.4.3 Between(4%-12%)1.5 Market by Application1.5.1 Global Feed Additive Nosiheptide Premix Market Size Growth Rate by Application1.5.2 Livestock1.5.3 Poultry1.6 Coronavirus Disease 2019 (Covid-19): Feed Additive Nosiheptide Premix Industry Impact1.6.1 How the Covid-19 is Affecting the Feed Additive Nosiheptide Premix Industry1.6.1.1 Feed Additive Nosiheptide Premix Business Impact Assessment Covid-191.6.1.2 Supply Chain Challenges1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Feed Additive Nosiheptide Premix Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-191.6.3.1 Government Measures to Combat Covid-19 Impact1.6.3.2 Proposal for Feed Additive Nosiheptide Premix Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered

2 Executive Summary2.1 Global Feed Additive Nosiheptide Premix Market Size Estimates and Forecasts2.1.1 Global Feed Additive Nosiheptide Premix Revenue 2015-20262.1.2 Global Feed Additive Nosiheptide Premix Sales 2015-20262.2 Feed Additive Nosiheptide Premix Market Size by Region: 2020 Versus 20262.2.1 Global Feed Additive Nosiheptide Premix Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Feed Additive Nosiheptide Premix Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Feed Additive Nosiheptide Premix Competitor Landscape by Players3.1 Feed Additive Nosiheptide Premix Sales by Manufacturers3.1.1 Feed Additive Nosiheptide Premix Sales by Manufacturers (2015-2020)3.1.2 Feed Additive Nosiheptide Premix Sales Market Share by Manufacturers (2015-2020)3.2 Feed Additive Nosiheptide Premix Revenue by Manufacturers3.2.1 Feed Additive Nosiheptide Premix Revenue by Manufacturers (2015-2020)3.2.2 Feed Additive Nosiheptide Premix Revenue Share by Manufacturers (2015-2020)3.2.3 Global Feed Additive Nosiheptide Premix Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Feed Additive Nosiheptide Premix Revenue in 20193.2.5 Global Feed Additive Nosiheptide Premix Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Feed Additive Nosiheptide Premix Price by Manufacturers3.4 Feed Additive Nosiheptide Premix Manufacturing Base Distribution, Product Types3.4.1 Feed Additive Nosiheptide Premix Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Feed Additive Nosiheptide Premix Product Type3.4.3 Date of International Manufacturers Enter into Feed Additive Nosiheptide Premix Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)4.1 Global Feed Additive Nosiheptide Premix Market Size by Type (2015-2020)4.1.1 Global Feed Additive Nosiheptide Premix Sales by Type (2015-2020)4.1.2 Global Feed Additive Nosiheptide Premix Revenue by Type (2015-2020)4.1.3 Feed Additive Nosiheptide Premix Average Selling Price (ASP) by Type (2015-2026)4.2 Global Feed Additive Nosiheptide Premix Market Size Forecast by Type (2021-2026)4.2.1 Global Feed Additive Nosiheptide Premix Sales Forecast by Type (2021-2026)4.2.2 Global Feed Additive Nosiheptide Premix Revenue Forecast by Type (2021-2026)4.2.3 Feed Additive Nosiheptide Premix Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Feed Additive Nosiheptide Premix Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)5.1 Global Feed Additive Nosiheptide Premix Market Size by Application (2015-2020)5.1.1 Global Feed Additive Nosiheptide Premix Sales by Application (2015-2020)5.1.2 Global Feed Additive Nosiheptide Premix Revenue by Application (2015-2020)5.1.3 Feed Additive Nosiheptide Premix Price by Application (2015-2020)5.2 Feed Additive Nosiheptide Premix Market Size Forecast by Application (2021-2026)5.2.1 Global Feed Additive Nosiheptide Premix Sales Forecast by Application (2021-2026)5.2.2 Global Feed Additive Nosiheptide Premix Revenue Forecast by Application (2021-2026)5.2.3 Global Feed Additive Nosiheptide Premix Price Forecast by Application (2021-2026)

6 North America6.1 North America Feed Additive Nosiheptide Premix by Country6.1.1 North America Feed Additive Nosiheptide Premix Sales by Country6.1.2 North America Feed Additive Nosiheptide Premix Revenue by Country6.1.3 U.S.6.1.4 Canada6.2 North America Feed Additive Nosiheptide Premix Market Facts & Figures by Type6.3 North America Feed Additive Nosiheptide Premix Market Facts & Figures by Application

7 Europe7.1 Europe Feed Additive Nosiheptide Premix by Country7.1.1 Europe Feed Additive Nosiheptide Premix Sales by Country7.1.2 Europe Feed Additive Nosiheptide Premix Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia7.2 Europe Feed Additive Nosiheptide Premix Market Facts & Figures by Type7.3 Europe Feed Additive Nosiheptide Premix Market Facts & Figures by Application

8 Asia Pacific8.1 Asia Pacific Feed Additive Nosiheptide Premix by Region8.1.1 Asia Pacific Feed Additive Nosiheptide Premix Sales by Region8.1.2 Asia Pacific Feed Additive Nosiheptide Premix Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam8.2 Asia Pacific Feed Additive Nosiheptide Premix Market Facts & Figures by Type8.3 Asia Pacific Feed Additive Nosiheptide Premix Market Facts & Figures by Application

9 Latin America9.1 Latin America Feed Additive Nosiheptide Premix by Country9.1.1 Latin America Feed Additive Nosiheptide Premix Sales by Country9.1.2 Latin America Feed Additive Nosiheptide Premix Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina9.2 Central & South America Feed Additive Nosiheptide Premix Market Facts & Figures by Type9.3 Central & South America Feed Additive Nosiheptide Premix Market Facts & Figures by Application

10 Middle East and Africa10.1 Middle East and Africa Feed Additive Nosiheptide Premix by Country10.1.1 Middle East and Africa Feed Additive Nosiheptide Premix Sales by Country10.1.2 Middle East and Africa Feed Additive Nosiheptide Premix Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 U.A.E10.2 Middle East and Africa Feed Additive Nosiheptide Premix Market Facts & Figures by Type10.3 Middle East and Africa Feed Additive Nosiheptide Premix Market Facts & Figures by Application

11 Company Profiles11.1 Mitsubishi Company11.1.1 Mitsubishi Company Corporation Information11.1.2 Mitsubishi Company Description, Business Overview and Total Revenue11.1.3 Mitsubishi Company Sales, Revenue and Gross Margin (2015-2020)11.1.4 Mitsubishi Company Feed Additive Nosiheptide Premix Products Offered11.1.5 Mitsubishi Company Recent Development11.2 Zhejiang Esigma Animal Health11.2.1 Zhejiang Esigma Animal Health Corporation Information11.2.2 Zhejiang Esigma Animal Health Description, Business Overview and Total Revenue11.2.3 Zhejiang Esigma Animal Health Sales, Revenue and Gross Margin (2015-2020)11.2.4 Zhejiang Esigma Animal Health Feed Additive Nosiheptide Premix Products Offered11.2.5 Zhejiang Esigma Animal Health Recent Development11.3 Anhui Wanbei Pharmaceutical11.3.1 Anhui Wanbei Pharmaceutical Corporation Information11.3.2 Anhui Wanbei Pharmaceutical Description, Business Overview and Total Revenue11.3.3 Anhui Wanbei Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)11.3.4 Anhui Wanbei Pharmaceutical Feed Additive Nosiheptide Premix Products Offered11.3.5 Anhui Wanbei Pharmaceutical Recent Development11.4 ZheJiang MingZhu Animal Health Products11.4.1 ZheJiang MingZhu Animal Health Products Corporation Information11.4.2 ZheJiang MingZhu Animal Health Products Description, Business Overview and Total Revenue11.4.3 ZheJiang MingZhu Animal Health Products Sales, Revenue and Gross Margin (2015-2020)11.4.4 ZheJiang MingZhu Animal Health Products Feed Additive Nosiheptide Premix Products Offered11.4.5 ZheJiang MingZhu Animal Health Products Recent Development11.5 Chattha Group11.5.1 Chattha Group Corporation Information11.5.2 Chattha Group Description, Business Overview and Total Revenue11.5.3 Chattha Group Sales, Revenue and Gross Margin (2015-2020)11.5.4 Chattha Group Feed Additive Nosiheptide Premix Products Offered11.5.5 Chattha Group Recent Development11.6 Zhejiang University Sunny Nutrition Technology11.6.1 Zhejiang University Sunny Nutrition Technology Corporation Information11.6.2 Zhejiang University Sunny Nutrition Technology Description, Business Overview and Total Revenue11.6.3 Zhejiang University Sunny Nutrition Technology Sales, Revenue and Gross Margin (2015-2020)11.6.4 Zhejiang University Sunny Nutrition Technology Feed Additive Nosiheptide Premix Products Offered11.6.5 Zhejiang University Sunny Nutrition Technology Recent Development11.7 Shandong Shengli Bioengineering11.7.1 Shandong Shengli Bioengineering Corporation Information11.7.2 Shandong Shengli Bioengineering Description, Business Overview and Total Revenue11.7.3 Shandong Shengli Bioengineering Sales, Revenue and Gross Margin (2015-2020)11.7.4 Shandong Shengli Bioengineering Feed Additive Nosiheptide Premix Products Offered11.7.5 Shandong Shengli Bioengineering Recent Development11.8 Fenghe Bio-Technology11.8.1 Fenghe Bio-Technology Corporation Information11.8.2 Fenghe Bio-Technology Description, Business Overview and Total Revenue11.8.3 Fenghe Bio-Technology Sales, Revenue and Gross Margin (2015-2020)11.8.4 Fenghe Bio-Technology Feed Additive Nosiheptide Premix Products Offered11.8.5 Fenghe Bio-Technology Recent Development11.9 Bornsun Bioengineering11.9.1 Bornsun Bioengineering Corporation Information11.9.2 Bornsun Bioengineering Description, Business Overview and Total Revenue11.9.3 Bornsun Bioengineering Sales, Revenue and Gross Margin (2015-2020)11.9.4 Bornsun Bioengineering Feed Additive Nosiheptide Premix Products Offered11.9.5 Bornsun Bioengineering Recent Development11.1 Mitsubishi Company11.1.1 Mitsubishi Company Corporation Information11.1.2 Mitsubishi Company Description, Business Overview and Total Revenue11.1.3 Mitsubishi Company Sales, Revenue and Gross Margin (2015-2020)11.1.4 Mitsubishi Company Feed Additive Nosiheptide Premix Products Offered11.1.5 Mitsubishi Company Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)12.1 Feed Additive Nosiheptide Premix Market Estimates and Projections by Region12.1.1 Global Feed Additive Nosiheptide Premix Sales Forecast by Regions 2021-202612.1.2 Global Feed Additive Nosiheptide Premix Revenue Forecast by Regions 2021-202612.2 North America Feed Additive Nosiheptide Premix Market Size Forecast (2021-2026)12.2.1 North America: Feed Additive Nosiheptide Premix Sales Forecast (2021-2026)12.2.2 North America: Feed Additive Nosiheptide Premix Revenue Forecast (2021-2026)12.2.3 North America: Feed Additive Nosiheptide Premix Market Size Forecast by Country (2021-2026)12.3 Europe Feed Additive Nosiheptide Premix Market Size Forecast (2021-2026)12.3.1 Europe: Feed Additive Nosiheptide Premix Sales Forecast (2021-2026)12.3.2 Europe: Feed Additive Nosiheptide Premix Revenue Forecast (2021-2026)12.3.3 Europe: Feed Additive Nosiheptide Premix Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Feed Additive Nosiheptide Premix Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Feed Additive Nosiheptide Premix Sales Forecast (2021-2026)12.4.2 Asia Pacific: Feed Additive Nosiheptide Premix Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Feed Additive Nosiheptide Premix Market Size Forecast by Region (2021-2026)12.5 Latin America Feed Additive Nosiheptide Premix Market Size Forecast (2021-2026)12.5.1 Latin America: Feed Additive Nosiheptide Premix Sales Forecast (2021-2026)12.5.2 Latin America: Feed Additive Nosiheptide Premix Revenue Forecast (2021-2026)12.5.3 Latin America: Feed Additive Nosiheptide Premix Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Feed Additive Nosiheptide Premix Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Feed Additive Nosiheptide Premix Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Feed Additive Nosiheptide Premix Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Feed Additive Nosiheptide Premix Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Feed Additive Nosiheptide Premix Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Feed Additive Nosiheptide Premix Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details16.3 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

The rest is here:
Feed Additive Nosiheptide Premix Market Analysis, Market Size, In-Depth Insights, Growth and Forecast to 2026| Mitsubishi Company, Zhejiang Esigma...

‘Foundational for the Development of the Field’ | The UCSB Current – The UCSB Current

The UC Santa Barbara Academic Senate has awarded Distinguished Professor Alison Butler the Faculty Research Lecture Award for 2020.

I congratulate Alison on receiving the highest honor bestowed by UC Santa Barbaras faculty senate, said Pierre Wiltzius, executive dean of the College of Letters and Science. As a pioneer in the field of metallo-biochemistry, and a leading scholar on this campus, she is most deserving of this recognition.

Said Steve Buratto, professor and chair of the chemistry and biochemistry department, Professor Butler is one of our most highly decorated faculty members. For over 30 years she has exemplified what is to be a truly great researcher: highly creative with an interdisciplinary spirit coupled with hard work. Her colleagues in the Department of Chemistry and Biochemistry are very proud of her and can think of no one more deserving of this award.

Im so grateful, Butler said, I couldnt have found a better department to have started my career, and in fact to have actually developed my whole career.

Butlers research focuses on bio-inorganic chemistry with an emphasis on the roles of metal ions in metallo-enzymes. Although the topic may seem obscure, its of no small importance. All life depends on metallo-enzymes to function, Butler said, from breathing to photosynthesis to nitrogen fixation.

She is particularly curious about the molecules and processes by which microbes acquire the transition metals they need to grow, which can be quite difficult to obtain from the environment. Transition metals are often locked away in oxides and minerals or in the complex proteins of host organisms.

To acquire the metals they so desperately need, many bacteria secrete small molecules called siderophores that scour the surroundings of a particular metal, most often iron. Butler is working to predict the forms and functions of these molecules using genomics, as well as what other metal ions microbes may sequester using these and other microbial ligands.

Butler suspects these small molecules may have additional functions as well, completely unrelated to metal sequestration. For instance, she and her colleagues are looking at the wet adhesion properties of siderophore cyclic trichrysobactin, which resembles and mimics the proteins that keep mussels secured to rocks.

With its unique chemistry and signs of applicability to fields such as materials and medicine, this subject has begun to attract a number of other researchers. I feel like we played a small part in opening up the excitement and importance of metallo-biochemistry and bio-inorganic chemistry of the marine environment, Butler said.

She is the recipient of numerous honors and awards, including the American Chemical Societys Alfred Bader Award in 2018 and the Cope Scholar Award the following year. The society generally specifies a five-year span between awards unless each award recognizes distinct achievements, making Butlers recognition truly exceptional.

Also in 2019, she was elected Fellow of the American Academy of Arts and Sciences as well as of the Royal Society of Chemistry, who additionally bestowed upon her the societys Inorganic Reaction Mechanisms Award.

Butler has mentored 37 doctoral students and postdoctoral scholars, many of whom have gone on to develop stellar careers of their own. She has found time to share her leadership capability with the campus, serving as the vice chair of the chemistry department, associate dean of bioengineering, and currently as associate vice chancellor for academic personnel.

In announcing the Faculty Research Lecture Award, the committee noted Butlers seminal contributions to research, citing her for having expanded the field of siderophore research, discovering new classes of siderophores, and new reactivity of the iron(III)-siderophore complexes. Of specific note was her discovery of the photoreactivity of Fe(III)-bound to siderophores with alpha-hydroxy carboxylic acids. Researchers have worked with some of these compounds for 40 years without ever recognizing this property.

To quote one of Butlers nominators: Her work is foundational for the development of the field and the understanding of biological productivity on Earth.

Butler looks forward to sharing her enthusiasm for bio-inorganic chemistry with the community when she gives her lecture. As daunting as it feels, when I actually get down to thinking about how to present this, Im really excited, she said. She hopes to include audience participation and demonstrations in her lecture.

Reflecting on her selection for the Faculty Research Lecture Award, Butler said, Its totally special because its really my immediate community. Who knew, when I started off at UCSB as an assistant professor in 1986, that this is where I could get.

Visit link:
'Foundational for the Development of the Field' | The UCSB Current - The UCSB Current

Scientists Create Music to Represent Protein Structure of the Coronavirus – VOA Learning English

Scientists say they have used artificial intelligence (AI) to create music to represent the protein structure of the new coronavirus.

Researchers used machine-learning methods to make the music, which they say may help them better understand the virus.

The research team assigned musical notes to amino acids that make up the so-called spiked protein that infects human cells. Machine learning was then used to turn the protein and structural information into a nearly two-hour piece of classical music.

Markus Buehler of the Massachusetts Institute of Technology (MIT) led the research team. He recently reported the results in a study appearing in the publication APL Bioengineering.

Buehler told the Reuters news agency that turning the protein data into music lets people gain a better understanding of something they cannot see. You would need many different images, many different magnifications to see with your eyes, what your ears can pick up with just a couple of seconds of music, he said.

Buehler added that although the proteins themselves speak a language we dont understand, music can be a way to improve that understanding. If we are going to be able to solve that language, we could solve many problems not only for this disease, but for many other diseases.

The finished selection was uploaded to the music sharing website SoundCloud for the public to hear.

Listeners of the early part of the piece described it with words such as beautiful, interesting, calm, and nature.

Buehler said this part of the music represents the ease at which the spiked protein enters the human cell, making the coronavirus highly contagious. He noted that the virus is very good at tricking the cell to open the doors to infect someone.

As the virus then reproduces and the spiked protein attaches to more cells, the music becomes louder, faster and more intense. One SoundCloud user noted that this part could represent one of the first signs of the virus in humans, a high body temperature. Others described the more intense part of the music as scary and sad.

The researchers say a possible next step could be to use the musical method to design an antibody to attack the virus.

Buehler said the fast spread of the new coronavirus had made it important to open our brains to other ways of processing information. He noted that the usual antibody design methods require a large number of proteins and a long testing process. In the current crisis, we dont have the luxury of time, Buehler said.

The study states that musical representations of proteins could also be used as a tool to help design new protein materials for many uses in biology, medicine and engineering.

Im Bryan Lynn.

Bryan Lynn wrote this story for VOA Learning English, based on reports from Reuters, the Massachusetts Institute of Technology and APL Bioengineering. Ashley Thompson was the editor.

We want to hear from you. Write to us in the Comments section, and visit our Facebook page.

________________________________________________________________

artificial intelligence n. the power of a machine to copy intelligent human behavior

classical adj. representing a high standard or traditional, long-established style

magnification n. the process of making something look bigger than it is

calm adj. relaxed and not worried

contagious adj. having a sickness that can be passed on to someone else

rhythm n. a regular, repeating pattern of sound

antibody n. a substance produced in the blood to fight disease

luxury n. something costly that you enjoy but do not need

What are your thoughts on the music examples? Write to us in the Comments section, and visit our Facebook page.

Read this article:
Scientists Create Music to Represent Protein Structure of the Coronavirus - VOA Learning English

The Fannie and John Hertz Foundation Announces 2020 Fellows – Newswise

Newswise The Fannie and John Hertz Foundation, a nonprofit organization dedicated to empowering the most promising innovators in science and technology, has announced the 2020 recipients of the Hertz Fellowship.

The Hertz Fellowship supports the research of PhD students who demonstrate the greatest potential to tackle the most urgent problems facing society. This years fellowships will fund 16 researchers whose goals range from developing drugs more quickly, cheaply, and effectively, to advancing artificial intelligence to creating a carbon-neutral future.

One of the most prestigious awards of its kind, the Hertz Fellowship supports five years of graduate research and the freedom to pursue innovative ideas, wherever they may lead. Hertz Fellows also receive lifelong professional support, including mentoring and networking within a connected, influential community of more than 1,200 leaders in science and technology, each of whom has been awarded the Hertz Fellowship since 1963.

The pursuits of our 2020 Hertz Fellows embody the type of bold, risk-taking research that the Hertz Foundation has supported for almost six decades, said Robbee Baker Kosak, president of the Fannie and John Hertz Foundation. By funding innovative thinkers and connecting visionary researchers across generations, geography, and disciplines, we create the conditions for our fellows to have an exponential impact on the most pressing problems facing our nation and world.

Selected through a rigorous process, including in-depth interviews with some of the nations top scientists, engineers, and mathematicians, the newest Hertz Fellows were selected from a pool of more than 800 applicants from 24 universities across the nation.

We strive to identify young researchers with the vision and drive to achieve the breakthroughs that are needed today in science and technology, said Philip Welkhoff, senior interviewer and member of the board of directors at the Hertz Foundation, as well as the malaria program director at the Bill & Melinda Gates Foundation. As a society, we benefit tremendously from empowering them with the freedom to leap into the unknown and explore the possibilities.

The 2020 class joins a community of fellows whose transformative research and daring innovation impact our lives every day. Hertz Fellows are developing a drug therapy to restore hearing, data-driven methods to detect cyber threats, technology to genetically eradicate invasive plant species, and immunotherapy to support universal organ transplants. Theyve uncovered contraband nuclear weapons, created hack-proof drones for the military, and proven the Big Bang theory of the origin of the universe.

Many Hertz Fellows are currently focusing their work on addressing the COVID-19 pandemic. Anna Bershteyn is co-principal investigator in a clinical trial to determine if the antimalarial drug hydroxychloroquine can prevent COVID-19 from developing in people whove been recently exposed to the virus. In work published in Nature, Cheri Ackerman and Cameron Myhrvold collaborated on the development of diagnostic technology that can simultaneously test 1,000 samples for 160 different viruses.

Over the foundations 57-year history of awarding fellowships, Hertz Fellows have established a remarkable track record of accomplishments. Their ranks include two Nobel laureates; two MacArthur Fellows; eight recipients of the Breakthrough Prize; and winners of the Turing Award, the Fields Medal, the National Medal of Technology, and the Wall Street Journal Technology Innovation Award. In addition, 43 are members of the National Academies of Sciences, Engineering, and Medicine, and 12 have been included in Forbes magazines 30 under 30 list. Hertz Fellows have founded more than 200 companies and hold more than 3,000 patents.

Introducing the 2020 Hertz Fellows

Fellows are listed along with their graduate institution and field of interest.

Alexander (Sasha) Alabugin (California Institute of Technology; Chemistry) Alexander Alabugin aspires to advance energy science by characterizing and controlling elementary transactions of small molecules, protons, photons, and electrons. His goal is to unravel inorganic reaction mechanisms with techniques ranging from x-ray absorption to electron resonance and Mssbauer spectroscopy. A senior in chemistry at Massachusetts Institute of Technology, Alexander is also a fellow of the National Science Foundation.

Daine Danielson (University of Chicago; Physics) An Eckhardt Graduate Scholar in the Enrico Fermi Institute at the University of Chicago, Daine Danielson envisions a world in which a global network of neutrino-based nuclear monitoring technologies is used to root out clandestine weapons manufacturing, reducing the threat of nuclear terrorism and war. His research explores the phenomenology of fundamental particles and fields, developing novel applications toward nuclear security and nonproliferation, and deepening our understanding of the natural world. Cofounder and chief architect of the medical education platform Whitekoat, Inc., he holds a bachelors in computational physics with a minor in mathematics from the University of California, Davis.

Alyssa Dayan (University of California, Berkeley; Computer Science) Alyssa Dayan hopes to further our knowledge about intelligence and cognition while enabling smarter new technologies that can help the world. A machine learning research scientist on the research and development team at Uber Advanced Technologies Group, where she works on simulation and prediction for autonomous vehicles, she received a bachelors in mathematics with computer science from Massachusetts Institute of Technology in 2018.

Marisa Gaetz (Massachusetts Institute of Technology; Mathematics) Exploring the numerous connections between physics and representation theory, Marisa Gaetz conducts research with potential applications for quantum mechanics. A senior at Massachusetts Institute of Technology, she is graduating with a bachelors degree in mathematics and a minor in philosophy. Outside of her research, Marisa works to improve diversity and inclusivity within the mathematics community. A leader of the MIT Prison Education Initiative, she also focuses on using education and technology to improve the criminal justice system and reduce mass incarceration.

Jakob Grzesik (Stanford University; Electrical Engineering, Physics) By connecting engineering design and fundamental physics, Jakob Grzesik hopes to create new quantum-based technologies to address problems in energy, computation, and communication. A senior completing dual degrees in electrical engineering and mathematics at Rice University, Jakob aims to apply his growing expertise in optical properties of nanoscale materials to develop novel photonic technologies for applications in quantum computation, communication, and energy.

Hannah Lawrence (Massachusetts Institute of Technology; Computer Science) Hannah Lawrence is interested in developing theoretical foundations for new algorithms at the interface of machine learning, data science, and signal processing, with potential impact in drug development and other applications. She is particularly interested in broadening our understanding of how structure and scientifically informed priors can be incorporated into learning problems and frameworks. Currently a research analyst at the Center for Computational Mathematics at the Flatiron Institute, Hannah is a 2019 graduate of Yale University with a bachelors in applied mathematics and computer science.

Isaac Metcalf (Rice University; Materials Science) Isaac Metcalf hopes his research can help push the nation and world toward a carbon-neutral future. A senior at Massachusetts Institute of Technology, Isaac is graduating with dual degrees in physics and materials science. He will join the Materials Physics for Energy Management group at Rice University, where he plans to focus his research on increasing the efficiency and stability of two-dimensional perovskite photovoltaics.

Nolan Peard (Stanford University; Physics) Nolan Peard is interested in light-matter interactions and their applications in chemistry and quantum optics. He is particularly interested in the potential of optical techniques to control quantum states of molecules and their interactions, enabling fundamental understanding of chemistry that may be used to create materials and molecules with new capabilities. He is graduating with dual degrees in physics and music from Massachusetts Institute of Technology.

Maya Sankar (Stanford University; Mathematics) Maya Sankar is interested in researching combinatorics and graph theory, particularly studying extremal problems and their ties to theoretical computer science. A senior at Massachusetts Institute of Technology, she is graduating with dual degrees in mathematics and computer science and a minor in music.

Jillian Silbert (Harvard University; Quantitative Biology and Bioengineering) Combining computational and experimental methodologies in her biological research, Jillian Silbert believes that interdisciplinary work is the key to furthering scientific knowledge and crafting creative solutions to environmental and health issues. She plans to study interactions within the bacterial communities and applications of microbiology research to current environmental and biomedical issues. Jillian graduated magna cum laude from Princeton University in 2018, with a bachelors degree in molecular biology and a minor in quantitative and computational biology. She studied as a Fulbright Scholar at the National Center of Biotechnology in Madrid.

Vikram Sundar (Massachusetts Institute of Technology; Computational and Systems Biology) By tackling difficult questions in computational structural biology, Vikram Sundar hopes to help scientists develop drugs more quickly, cheaply, and effectively. He plans to combine his knowledge of physics and machine learning to tackle problems ranging from understanding protein/ligand binding for drug discovery to designing proteins with specific functions. Vikram received a bachelors degree in mathematics and a masters degree in physics from Harvard University in 2018 and a masters degree in chemistry from the University of Cambridge, where he was a Churchill Scholar, in 2019. He is currently an AI resident at Google.

Constantine Tzouanas (Massachusetts Institute of Technology; Biological Engineering) Constantine Tzouanass long-term goal is to engineer biological systems to address pressing needs, from organ transplants to environmentally responsible chemical production. A National Science Foundation Graduate Research Fellow in the Harvard-MIT Health Sciences and Technology program, he is pursuing a PhD in medical engineering and medical physics with a concentration in biological engineering. He graduated summa cum laude from Rice University in 2019 with a bachelors degree in bioengineering and a minor in neuroscience.

Nico Valdes Meller (Massachusetts Institute of Technology; Physics) Nico Valdes Meller hopes that a more profound understanding of networks can help us be better prepared for the technological revolutions to come. Aiming to work at the interface of theoretical physics and its applications by studying field theory, gravitation, and quantum information, Nico will pursue his PhD after completing a one-year masters program at Perimeter Scholars International. He received a bachelors degree in physics from the University of Chile.

Sophie Walton (Stanford University; Biophysics) By exploring the limits and capabilities of biological systems and such fundamental processes as evolution, Sophie Walton hopes to further the applications of biophysics research. A senior at California Institute of Technology, she is graduating with a bachelors degree in bioengineering.

Maxwell Wang (Carnegie Mellon University/University of Pittsburgh; Machine Learning and Neuroscience) An MD/PhD student at the University of Pittsburgh and Carnegie Mellon University, Maxwell Wang is conducting research with the goal of understanding how brain networks change during neuro-interventions, such as deep brain stimulation, and to link these changes to end-points such as symptom improvement and adverse side-effect profiles. A graduate of Washington University in St. Louis with a bachelors degree in electrical engineering, he began taking math courses at the University of Illinois, Urbana-Champaign, when he was in fifth grade and published his first research paper while a young teenager.

Katherine Xiang (Harvard University; Physics) The role of physics in biology motivates Katherine Xiang to understand the natural world better, particularly in energy flow and transport in biological systems. A senior at Johns Hopkins University, she is graduating with a bachelors degree in physics, biophysics, and mathematics.

About the Fannie and John Hertz Foundation

The Fannie and John Hertz Foundation identifies the nations most promising innovators in science and technology, and empowers them to pursue solutions to the worlds toughest challenges. Launched in 1963, the Hertz Fellowship is the most exclusive fellowship program in the United States, fueling more than 1,200 leaders, disruptors, and creators who apply their remarkable talent where it's needed mostfrom improving human health to protecting the health of the planet. Hertz Fellows hold 3,000+ patents, have founded 200+ companies, and have received 200+ major national and international awards, including two Nobel Prizes, eight Breakthrough Prizes, the National Medal of Technology, the Fields Medal, and the Turing Award. Learn more at https://HertzFoundation.org.

Originally posted here:
The Fannie and John Hertz Foundation Announces 2020 Fellows - Newswise

Refrigerated Dryers Market Excellent Growth 2020 | also understand the impact of COVID-19 situation across the globe Cole Reports – Cole of Duty

Refrigerated Dryers Market Outlooks 2020

The Refrigerated Dryersmarket report is the most important research for who looks for complete information on Refrigerated Dryersmarkets. The report covers all information on the Global and regional markets including old and future trends for market demand, size, trading, supply, competitors, and prices as well as Global predominant vendors information. the report also provides a complete overview of Refrigerated Dryersmarkets; including Top Players or vendors, application, Type, Share, and latest market trends.

Refrigerated Dryers are designed for offering recipes to the users.Its tough to come up with inspiration for an exciting new meal idea every day though, and thats where a good recipe app comes into play. They wont actually cook the meal for you but with some apps offering great step by step instructions, even the most inexperienced of chefs should be able to get to grips with these.

Click the link to Get a Free Sample Copy of the [emailprotected]https://garnerinsights.com/Global-Refrigerated-Dryers-Market-Insights-Forecast-to-2025#request-sample

The key manufacturers covered in this report: Sumake, Pneumatic Products, OMI Italy, Mikropor, Ingersoll Rand, Airpol,

Segmentation by Product Type: Intermittent Type, Continuous Type,

Segmentation by Application: Bioengineering, Pharmaceutical Industry, Food Industry, Other,

The report has been prepared based on the synthesis, analysis, and interpretation of information about the Refrigerated Dryersmarketcollected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players.

The industry report also includes the impact of COVID-19 on the global market.

Stay at home | Stay safe

Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. The study then describes the drivers and restraints forthe marketalong with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the market on a global level.Finally, the report in order to meet the users requirements is also available.

Thereport also presents the historic, current and expected future market size, position, of the Refrigerated Dryersindustry. The report further signifies the upcoming challenges, restraints and unique opportunities in the Refrigerated Dryersmarket. The report demonstrates the trends and technological advancement ongoing in the Refrigerated Dryersindustry. In addition to the current inclinations over technologies and capabilities, the report also presents the variable structure of the market, worldwide.

Grab Your Report at an Impressive Discount! Please click Here@ https://garnerinsights.com/Global-Refrigerated-Dryers-Market-Insights-Forecast-to-2025#discount

The information presented in this report provides an overview of the latest trends and development plans, patterns, and policies observed in the global market. Moreover, the study provides an analysis of the latest events such as the technological advancements and the product launches and their consequences on the global Refrigerated Dryersmarket.

The research methodology of the market involves both primary as well as secondary research data sources. It commits different factors affecting Refrigerated Dryersindustry such as market environment, various policies of the government, past data and market trends, technological advancements, upcoming innovations, market risk factors, market restraints, and challenges in the industry.

Objectives of the Report:

At last, It includes the methodical description of the various factors such as the Refrigerated Dryersmarket growth and a piece ofDetailed information about the different companys revenue, growth, technological developments, production, and the various other strategic developments.

Read Descriptive list of Full Research Reports With [emailprotected]:https://garnerinsights.com/Global-Refrigerated-Dryers-Market-Insights-Forecast-to-2025

If you have any special requirements, please let us know and we will offer you the report as you want.

Read the original post:
Refrigerated Dryers Market Excellent Growth 2020 | also understand the impact of COVID-19 situation across the globe Cole Reports - Cole of Duty

international community of the United States declares that the coronavirus "is neither of human origin nor genetically modified" – The Press…

Washington The US intelligence community has concluded that the coronavirus is neither of human origin nor genetically modified, but investigations into the origins of the epidemic are underway, said the office of the director of national intelligence (ODNI) on Thursday. ).

The entire intelligence community has always provided essential support to American policy makers and those who have responded to the COVID-19 virus, which originated in China, ODNI said in a statement. The intelligence community also agrees with the broad scientific consensus that the COVID-19 virus was not created by humans or genetically modified.

ODNI said the intelligence community will continue to scrutinize emerging information and intelligence to determine if the epidemic started through contact with infected animals or if it was the result of an accident in a laboratory in Wuhan .

The statement comes amid growing questions about whether the U.S. intelligence community is being unduly pressured by policymakers to identify a link between the origin of the virus and infectious disease research facilities. in China.

American intelligence agencies have been exploring, but did not find any concrete evidence to support it, a theory that the coronavirus escaped from a Chinese laboratory. The possibility that the virus is from bioengineering rather than natural origin has been ruled out by government officials and scientists, a position reiterated on Thursday by ODNI.

More than 61,000 Americans have died from COVID-19, the disease caused by the virus, and more than a million have been infected, according to Johns Hopkins University.

Senior administration officials, including President Trump and Secretary of State Mike Pompeo, have blamed Beijing in recent weeks for hiding the first data on the spread of the virus in China, which they say has hindered effective global response.

In one interview with Reuters Trump said on Wednesday that Chinas management of the epidemic was due in part to the desire to see him lose his re-election in November, and that his administration weighed undetermined consequences. There are a lot of things I can do, he said.

Pompeo, a well-known Chinese hawk, accused China of continued obfuscation and hinted at future measures to hold it responsible for the losses caused by the pandemic.

I am still concerned that the Chinese Communist Party is not telling us about everything that is going on in all the laboratories, in fact each of the laboratories, all over China today, he said in a statement. communicated. interview with Fox News.

The New York Times reported Pompeo was part of a group of senior administration officials who urged intelligence agencies to obtain information on the origins of the virus on Thursday.

Analysts would generally be responsible for presenting the information they have collected in a factual and apolitical manner, and it would be incumbent on intelligence community leaders to appeal to policy makers who publicly overestimate or distort the information they have received.

It is not uncommon for a white house to charge the IC on issues that are sometimes politically charged, said Marc Polymeropoulos, a former CIA senior operations officer who retired last spring. What is essential is that CI analysts be allowed to carry out an all-source assessment, without political interference.

In the end, whatever the analytical conclusion reached, often the White House political actors may not be satisfied, he added. Its better to do it right, every time.

Source > https://www.cbsnews.com/news/coronavirus-us-intelligence-community-china-odni/

The rest is here:
international community of the United States declares that the coronavirus "is neither of human origin nor genetically modified" - The Press...

Rice University ignites innovation in response to COVID-19 crisis – TMC News – Texas Medical Center News

The Rice University campus may be uncharacteristically quiet these days, but that doesnt mean its staff and student population are riding out the COVID-19 pandemic idly. In fact, its just the opposite.

Since March, when the university announced that classes would shift to online learning for the remainder of the semester, a host of efforts have emerged from assembling care packages for essential employees to engineering lifesaving devices and establishing new research aimed at COVID-19 solutions.

I have been amazed, but not surprised, said David Leebron, president of Rice University. People want to contribute wherever their skills are, whether its data science, sociology, understanding differential impacts, maybe even understanding the history of contagionsall things we can learn from. People all over the university, they got themselves settled, we got folks off campus and now what they want to do is say: How can we help?

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::Looking for the latest on the CORONAVIRUS? Read our daily updates HERE.::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

From across disciplines that appear to be unlikely partners, students and staff members have found ways to contribute. The universitys Moody Center for the Arts has transformed their studio space into a production facility for face shields for medical workers; MBA students at the Jones Graduate School of Business established a business model that provides snacks for clinicians while boosting the local economy; and the Rice Athletics staff put together generous care packages for medical workers across the Texas Medical Center as a gesture of appreciation for work on the front line.

Among one of the most innovative solutions is an automated bag valve mask ventilation unit originally designed by engineering undergraduates at the Oshman Engineering Design Kitchen (OEDK), a dedicated hub for students to design and prototype solutions for real-world engineering challenges. As news of ventilator shortages in areas hit hard by COVID-19 grew, an online video of the unit began growing in popularity, even piquing the interest of the U.S. Department of Defense and the U.S. Navy.

The students who created the original unit have graduated, so an OEDK team collaborated with global health design firm Metric Technologies and reimagined the design so that it was easier to put together as a do-it-yourself-type kit.

Our technicians got together with one whiz-kid student and decided to redesign it and make it super simple, said Amy Kavalewitz, OEDK executive director. Working with Dr. Rohith Malya from Baylor as our advisor, they redesigned it in a way where, if you had the tools and you had the equipment and you had some basic knowledge of how to build a device, you could put one of these together.

Malya, who is an assistant professor of emergency medicine at Baylor College of Medicine, an adjunct assistant professor of bioengineering at Rice, associate of theRice 360 Institute for Global Healthand a principal at Metric Technologies, worked closely with Danny Blacker, the OEDKs engineering design supervisor for the mechanical efforts, and Rice University senior Thomas Herring, who led work on the programming and electrical components.

Named the ApolloBVM (BVM stands for bag valve mask), the device is not intended to be used in place of a ventilator when one is available, but rather as a bridge device. While typical bag valve masks pump air into the lungs by hand, this device is automatedmaking it highly desirable for patients in need of continuous support.

In early April, the team published instructions for the unit online for anyone who wished to build one. The cost for the parts is less than $300. Kavalewitz said that since making the plans public, more than 2,000 people from 105 different countries have registered for the download.

In the U.S., were pretty fortunate in a lot of ways because there are a lot of people that are going to be able to generate supplement-type ventilators to help the COVID efforts here, but there is a real worry about the global impact this is havingand there are many communities with hospitals that dont have ventilators at all, Kavalewitz said. We say all the time that if this device helps one person survive, then every bit of this effort was worth it.

She added that the OEDK and Metric Technologies are looking at compiling a kit for individuals without access to the raw supplies, especially those in low-resource settings who may not have 3D printers.

To further support research across disciplines, Rice has also created a COVID-19 Research Fund to help provide grants for Rice faculty working on COVID-related work, especially efforts geared toward accelerating research or the production of materials or reagents that would have immediate impact on the Houston community. The fund hasalready awarded an initial round of grants for projects focused on developing affordable diagnostic tools, advanced surgical masks, coronavirus detection methods in wastewater and voter safety.

The university also opened two dormitories for Texas Medical Center personnel who need to be in close proximity to their institutions. In a message to the Rice community on April 5, Leebron wrote that the Wiess and Hanszen residential colleges will enable TMC workers to live near their assignments while working the necessary hours during the crisis while offering a better opportunity for rest. The colleges are connected and are almost directly across the street from several TMC institutions.

This was a circumstance in which we thought we had to step in and do what we could to help the people who are really sacrificing to deliver the necessary care to treat the increasing number of victims of COVID-19, Leebron said. We feel very privileged to be here in Houston. We feel privileged to be part of the Texas Medical Center. And even though we dont provide medical care, we do think we have things we can contribute and thats what were doing.

More:
Rice University ignites innovation in response to COVID-19 crisis - TMC News - Texas Medical Center News

A shot in the arm for social sciences – The Conservative Woman

THERE is no doubt that the teaching of history in schools and at university has become drearily Left-wing, whether in its uncritical portrayals of communism, its demonisation of the West, or a personal favourite, the fixation on herstory. There is a serious lack of dissenting voices within academia to call out its agenda-driven, narrow-minded smugness. Journalist and author Douglas Murray said quite poignantly that it is one curiosity of academia in recent decades that it has found almost nothing it does not wish to deconstruct, apart from itself.

A study by the American Enterprise Institute (AEI) has reported that one fifth of social scientists in the United States describe themselves as Marxists, compared with only about 5 per cent who identify as conservative. The one diversity quota box that is always left unticked is the only one that really matters: diversity of opinion. For an academic article to be published, it must withstand the scrutiny of peer review. If the particular field of study is dominated by Left-wingers, it is easy to see how dissenting voices can be weeded out before publication.

Peer review is held up as sacrosanct by the academic community, despite it being a highly subjective process that is prone to confirmation bias and corruption. If there is a negative study that contradicts the postmodernist orthodoxy, you can bet it will not reach publication. After all, why would a journal seek to publish an article that serves to undermine its integrity? It is my view that the current peer review system in the social sciences should be vigorously restructured, or done away with completely.

With the unprecedented outbreak of Covid-19, the way we engage with academic research could be about to change completely. The urgent need for medical research in response to the pandemic has fuelled the demand for a different form of publishing, favouring open science on online forums called preprint servers. This is where academics and those outside the scientific field are able to engage with scientific literature that would normally be concealed behind a paywall. The conventional, bureaucratic model of peer review is incapable of coping in times of crisis as the usual form of publishing can take months or even years.

Its a great way to get preliminary results out and shared with the wider community, which can encourage collaboration and speed up the science, says Russ Altman, Professor of Bioengineering and former chairman of the Bioengineering Department at Stanford University. Of course, the negative is that its not peer reviewed, so people have to remember that what theyre reading might actually be slightly or totally wrong. But rather than creating a hazard, the introduction of open science has proved to be a great opportunity. A great benefit of open science is that it allows other researchers to comment and scrutinise works on online forums, increasing transparency. The general public can to tune in to cutting-edge scientific debate unfolding in real time which would normally not be accessible. Using traditional methods, this research might never reach publication, even if it is deemed to be correct.

After this pandemic has subsided, it remains to be seen whether scientific research will revert to the traditional methods of publication. But preprint servers have proved to be a net success in times of crisis. This open method of publication has the potential to be a game-changer if applied the same way in the social sciences. Ideas will become more accessible and can be challenged by not just a small number of academics, but the wider community. Peer review, in its current form, is a sacred cow that needs slaughtering.

- Advertisement -

Read the original:
A shot in the arm for social sciences - The Conservative Woman

Global Bio-decontamination Equipment Market Size, Growth and Forecast to 2024 Cole Reports – Cole of Duty

A recently released report titledGlobal Bio-decontamination Equipment Market Growth (Status and Outlook) 2020-2024is made covering in-depth analysis of market size, commercialization aspects, profit estimations, market share, and revenue forecast of the industry from 2020 to 2024 time-frame. The report provides details on every category of the global Bio-decontamination Equipment market like the product, technology, application, and end-user. It explicitly highlights the competitive status of key players focusing on growth strategies implemented by the service providers within the projection timeline while focusing on their portfolio and regional expansion ventures.

Ask For Sample Report @ https://www.reportspedia.com/report/manufacturing-and-construction/global-bio-decontamination-equipment-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/2222 #request_sample

The report includes data analysis about the market status, competition pattern, advantages and disadvantages of enterprise products, development trends, and regional industrial layout characteristics. Later the study throws light on the product scope, market opportunities, market risk, and market driving force as well as provides top manufacturers sales, revenue, and price by regional and country wise analysis. The research report includes technical data, manufacturing plants analysis, and raw material sources analysis of the global Bio-decontamination Equipment industry.

Key Players:

STERIS Life ScienceBioquellFedegari GroupTOMI Environmental SolutionsJCE BiotechnologyHoworth Air TechnologyTailin BioEngineeringWeike Biological LaboratoryNoxilizer

If You Have Any Query, Ask Our Experts @ https://www.reportspedia.com/report/manufacturing-and-construction/global-bio-decontamination-equipment-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/2222 #inquiry_before_buying

The Bio-decontamination Equipment Market Segmentation By Types:

Chamber DecontaminationRoom Decontamination

The Bio-decontamination Equipment Market Segmentation By Applications:

Pharmaceutical ManufacturingBioscience ResearchHospital & Healthcare

A Comprehensive Structure of The Regional Scope:

For a complete understanding of the market dynamics, the global Bio-decontamination Equipment market is analyzed through key geographic areas, namely:Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries). The study comprises of details regarding the market share amassed by each region. Additionally, details about the growth prospects for all the regions have been specified in the report. The approximate growth rate to be recorded by each region throughout the forecast period has been stated within the research study.

Moreover, a team of experienced market research professionals and experts continuously tracks key industries to spot key developments, needs, and possible growth opportunities as well as marketing strategies, trends, future products, and rising opportunities. Comprehensive analysis of the historical data and contemporary global Bio-decontamination Equipment market scenario to interpret industry size, volume, share, growth, and sales have been given in the report.

Attractions of The Report:

Customization of the Report:

This report can be made-to-order the clients requirements. Please connect with our sales team (Mail Id), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on (+1(617)2752538) to share your research requirements.

Get Full Table of content @ https://www.reportspedia.com/report/manufacturing-and-construction/global-bio-decontamination-equipment-market-2019-by-manufacturers,-regions,-type-and-application,-forecast-to-2024/2222 #table_of_contents

Follow this link:
Global Bio-decontamination Equipment Market Size, Growth and Forecast to 2024 Cole Reports - Cole of Duty

Hanna Season 2: Everything you Want to know About The Series! – World Top Trend

- Advertisement -

Hanna is an action a series that is inspired by an action- thriller movie with the same name. It has an exciting plot filled with action sequences. Hanna is written and created by David Farr under the supervision of the manager Sarah Adina Smith.

This show is currently gaining a great deal of fame due to its distinctive bioengineering idea. It reveals how the life of a girl changes with changing to society that is healthy from the woods. Following a catchy season, fans are happy to watch the next season.

Hanna is an American Internet Series that was on -air on Prime Video in February 2019. From April 2019, the series was revived by Amazon for a Season two.

At a halt, the shoot of virtually all displays has been a result of a sudden epidemic of Corona Virus. The fans can anticipate a season 2 by 2021, based on the improvement of the condition of the Pandemic.

The figures were, as noticed in Season 1:

Esme Creed-Miles as Hanna, the lead for the seriesJoel Kinnaman as Erik Heller, her fatherMireille Enos as Marissa Wiegler, their nemesis CIA representativeJoanna Kulig as Hannas late mother, Johanna

The story revolves around Hanna, who was genetically enhanced for a super-soldier when shes born. She is that manner as part of the CIAs Utrax program. But there is a revelation that baby Hanna was stolen by Erik and he hid her in the jungle woods, where no one could find her.

After hiding her, he gave her training in survival and combat skills for fifteen long years. He had a realization that Hanna will call for a teenage life so that he was deciding to take her to a secure place. This came out because of difficulty due to abrupt vulnerability to Marissa and other CIA representatives directed by Jerome Sawyer.

The second season shows the way will their lives be affected by Eriks decision and will pick up the narrative from here.

- Advertisement -

See more here:
Hanna Season 2: Everything you Want to know About The Series! - World Top Trend

The Heat: COVID-19 and the race for a vaccine – CGTN America

Published April 10, 2020 at 12:31 PM

As the world struggles to contain the coronavirus, we begin with encouraging news from the United Kingdom. British Prime Minister Boris Johnson is reported to be out of intensive care at St. Thomas hospital where hes been cared for since Monday. A spokesperson from Downing Street said the prime minister is back on a ward where hes being closely monitored. The death toll continues to rise in the United States with more than 16, 000 deaths. The epicenter, New York state, reported its single worst day on Wednesday with 799 deaths. And, 6.6 million Americans filed for unemployment benefits, bringing the total number of claims to more than 16 million. Economists say the US unemployment rate is now 13%, the worst since the Great Depression.

CGTNs White House Correspondent Nathan King reports.

To discuss the impact of the coronavirus in the United States:

As the death toll rises from the coronavirus, scientists around the world are racing to find a vaccine that will protect people from getting sick.

To discuss this:

Related

Read more:
The Heat: COVID-19 and the race for a vaccine - CGTN America

University of Maryland lab supplies donated to local hospitals – WTOP

Two University of Maryland students noticed that there were a lot of useful items in local labs that could be used for health care workers fighting coronavirus.

Two University of Maryland students noticed that there were a lot of useful items in local labs that could be used for health care workers fighting coronavirus, and decided to do something about it.

We do have some of this equipment so it only made sense just to get it to the right places that need it immediately, said Christina Conrad, a Ph.D. student in the Department of Bioengineering at the University of Maryland.

Conrad, along with fellow student James Shamul, sent an email to their department to see if there were items in their labs that could be donated to those caring for patients during the coronavirus outbreak.

Conrad said the response was overwhelming.

From there, we started reaching out to the entire university.

Thirty-seven different labs including animal science, biology, physics and other departments replied and donated more than 24,000 pairs of gloves, 2,500 face masks, 137 disposable lab coats, more than 100 N95 masks, and multiple gallons of cleaning supplies.

Its been really just exciting to get a lot of generosity. A lot of people have come together, Conrad said.

They have donated the supplies to the Prince Georges County Heath Department, the University of Maryland Medical Center, Johns Hopkins and the Greater Baltimore Medical Center.

Its definitely a great way for me to spend my time right now since our labs are closed at Maryland, Conrad said. A lot of us Ph.D. students are focused on writing our dissertations or reading literature, so this has just been a really great activity to be involved and try to make a difference.

More Coronavirus News

Like WTOP on Facebook and follow @WTOP on Twitter to engage in conversation about this article and others.

Get breaking news and daily headlines delivered to your email inbox by signing up here.

2020 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

See the original post:
University of Maryland lab supplies donated to local hospitals - WTOP

Hundreds of coronavirus antibody tests given to Yale New Haven staff, patients – New Haven Register

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Firefighters from across the region visited Yale New Haven Hospital Thursday to express gratitude for the efforts of hospital workers during the coronavirus outbreak.

Hundreds of coronavirus antibody tests given to Yale New Haven staff, patients

NEW HAVEN Health care workers and COVID-19 patients at Yale New Haven Hospital are being tested to see if those exposed to the coronavirus have developed antibodies to the disease and what effect those antibodies have on the body.

The tests, designed by Yale University scientists, will help better explain how COVID-19 spreads and how widely the coronavirus has spread, according to a release. Health care workers who have developed antibodies may have developed immunity and be able to care for COVID-19 patients without fear that they will be infected again.

We want to know what proportion of people were infected and if antibodies protect you from re-infection once you come out of lockdown, said Dr. Albert Ko, chairman of the Yale School of Public Healths Department of Epidemiology.

The test has not been approved for general use in patients. Giving the test to hospitalized COVID-19 patients will help establish accuracy, the release said. Researchers hope the tests will help determine whether antibodies to the coronavirus, SARS-CoV-2, give immunity to COVID-19 or whether they may worsen the illness.

The concern is that antibodies in some cases can trigger an immune response known as a cytokine storm. Ko and team are also investigating whether antibodies against the SARS-CoV-2 virus can in some cases be harmful by helping trigger the devastating cytokine storm immune response that can fill lungs with fluid and cause heart and kidney failure, the release said.

Cytokines are proteins created by cells, including interferons and interleukins, which may be overproduced and result in excess fluid in the lungs. It is considered a likely cause of deaths in the 1918 flu pandemic, according to Physicians Weekly.

Understanding the quality of a patients antibody response is therefore very important in giving assurance that a person is immune, said Aaron Ring, assistant professor of immunobiology, in the release. Also, if harmful antibody responses can be identified, this may suggest new therapeutic strategies for COVID-19.

While the Food and Drug Administration is expected to approve antibody tests this week, the lack of tests has slowed the ability to investigate the development of antibodies. Ko, Ring and others began using tests developed at Yale. Hundreds of health care workers and COVID-19 patients have been tested and new tests are being developed to check whether antibodies are being produced in response to other viral proteins, the release said.

Antibodies are the part of the bodys response to infection. The flu virus produces antibodies, but there are different strains of the flu, and antibodies are only effective against one strain. On the other hand, antibodies also are created by exposure to the common cold, also a coronavirus,

One key question they hope to answer is whether antibodies generated by COVID-19 actually prevent re-infection, as they do against strains of flu virus. If so, policymakers may be able to relax social distancing guidelines for those who possess these antibodies, and allow them to re-enter the workforce. However, antibodies created after exposure to the common cold, which is also a coronavirus, do not protect from being exposed again. Not all antibodies are created equal, Ko said.

We need to know what drives protective responses to the virus to help spur vaccine development, Ko said.

Other members of the research team included Dr. Camila Odio, associate research scientist Arnau Casanovas Massana and bioengineering graduate student Feimei Liu.

See the rest here:
Hundreds of coronavirus antibody tests given to Yale New Haven staff, patients - New Haven Register

Intelligent Design and COVID-19: Take a Seat for This Criticism – Discovery Institute

Image: Fusion Medical Animation,viaUnsplash.

I have been replying to criticisms of ID scientists by historian Adam Shapiro (see here and here). You had better take a seat for Shapiros next assertion:

.. there has been no indication that the government has looked to intelligent design research nor consulted any intelligent designfavoring scientists to address the pandemic On May 4, National Institute of Allergy and Infectious Diseases Director Anthony Fauci gave aninterviewin which he stated: A number of very qualified evolutionary biologists have said that everything about the stepwise evolution over time strongly indicates that it [the SARS-CoV-2 virus] evolved in nature and then jumped species.

But, of course, every scientist who has addressed the question of design or no design in the COVID-19 virus has been doing intelligent design research. Anderson et al. (2020) used a benchmark for known specific methods of human bioengineering, compared the spike protein to that benchmark, and found that it fell short. Surely more work remains to be done, but if that wasnt ID reasoning, what is?

These scientists are using the principle of fine-tuning to assess the viral genome for markers of complex specified information that could not be present without human intervention. All questions about the possibility of human-designed origin of COVID are intelligent design questions. And these scientists, who are doing excellent implicit design research, draw conclusions about the design of the virus based on the evidence to which they have access, which is considerably more than the limited evidence that, again as far as I am personally aware, the small cadre of explicit ID scientists have available to them.

In keeping with the best tradition of intelligent design research, which comprises most biological research since antiquity, ID researchers are staying within the bounds of the evidence available to them. They refrain from drawing conclusions scientific in form but political in nature based on insufficient evidence. ID, Adam Shapiro thinks, could redeem itself as being apolitical precisely by playing politics with science. It is remarkable indeed that Dr. Shapiro a historian of science berates ID scientists for not reaching conclusions in the absence of adequate evidence while he fails to recognize the mountain of intelligent design research being conducted on the origin of COVID-19 in leading laboratories all over the world.

Continue reading here:
Intelligent Design and COVID-19: Take a Seat for This Criticism - Discovery Institute

Stanford researchers tackle COVID-19 from all angles – The Stanford Daily

Stanford researchers across disciplines and departments have launched research projects to tackle the COVID-19 pandemic and its effects on daily life with a wide range of approaches.

Scientists, physicians and engineers are collaborating to find drugs and vaccines for the disease, combat personal protective equipment (PPE) and ventilator shortages, test existing therapeutics in nationwide clinical trials and optimize the productivity of the work-from-home workforce.

Here, we highlight a few of many Stanford research projects.

Searching for therapeutics

Research to find treatments for COVID-19 has focused on discovering antibodies to enable peoples immune systems to fend off the virus that causes COVID-19, known as SARS-CoV-2, and finding drugs that target viral proteins or human cells that help the virus spread.

Toward the first aim, in late January, genetics M.D./Ph.D. student Binbin Chen and his colleagues started a project to identify fragments of SARS-CoV-2 that can be used for COVID-19 vaccines.

Vaccines are one of the most powerful tools to curb a pandemic and prevent its recurrence, Chen said. However, vaccine design is often a guessing game with new pathogens so artificial intelligence tools built upon immunology knowledge and data can provide a better educated guess and increase the chances of finding an effective vaccine.

Chen and his co-authors have made a list of vaccine candidates available in a bioRxiv preprint in an effort to help bring vaccines to the clinic. They are also organizing a long-term project to collect patient samples for future pandemics.

In the midst of the pandemic, Chen found many willing and readily accessible collaborators. Some of those volunteering to help out were from across the globe. A senior author of one of the first SARS-CoV-2 protein structure papers from China replied to Chens email within four hours. And, in addition to international help, Chen found assistance much closer to home.

I also live with one on my academic collaborators my husband so we get a lot done! Chen said.

Stefano Rensi Ph.D. 18, a research engineer in the bioengineering department, has taken a different approach to the problem of finding therapeutics: Repurpose existing drugs with the goal of getting them to the front lines as soon as possible.

Rensi and colleagues including bioengineering professor Russ Altman Ph.D. 89 M.D. 90 predicted that existing compounds can bind and inhibit a key protein transmembrane protease, serine 2 (TMPRSS2) that facilitates viral invasion of human cells.

Feeling a sense of urgency, Rensi has put other projects on hold to help out with the crisis. He believes others in the Stanford community and around the world have done the same.

People across institutions and industry are all sharing information, ideas and results, Rensi said. I cant think of any better use of our time or training than fighting a global pandemic.

As computational researchers, Rensi and his co-authors now collaborate with others to test their predicted compounds in experimental assays, or tests, to see if their drugs can inhibit the key enzyme required for the virus to enter and infect human cells.

If [the assays] pan out, we will advance to animal testing and then clinical trials, Rensi said.

Starting rapid, adaptive clinical trials

Others, including Kari Nadeau, professor of medicine and pediatrics, and Neera Ahuja, clinical professor of medicine, have worked to bring clinical trials sponsored by the National Institutes of Health (NIH) to Stanford.

Nadeau and Ahuja are spearheading a trial at Stanford that is also being conducted at 64 other sites globally to test the safety and efficacy of remdesivir in hospitalized adult patients diagnosed with COVID-19. Remdesivir is a novel antiviral drug originally developed as a treatment for Ebola; it mimics a building block of viral genetic material and works to prevent viral replication.

The goal of the collaboration between Nadeau, Ahuja and the NIH is to quickly make more treatment options available for COVID-19 patients.

In very rapid form, we were able to get the trial up, site-approved and open for enrollment in about a week, which is really unheard of, Ahuja said.

Nadeau was excited to be able to work with the NIH and expressed gratitude for physicians like Ahuja, who are balancing patient care with the coordination of new clinical trials to obtain much-needed data on therapies for COVID-19.

Because there is no current therapy, we should be compelled to be a part of the best clinical trials out there, Nadeau said.

Nadeau also pointed out that clinical trials must be designed to anticipate the potential genetic mutations of SARS-CoV-2, as viruses can gain resistance to single therapies, often necessitating combinations of multiple drugs.

There are methodologies in statistics and trial design adaptive trial design where you can combine more than one drug at a time, Nadeau said. Viruses are super smart and can develop resistance. So, we are going to start an adaptive trial design for combination therapies.

Coping with working from home

Researchers like Pablo Paredes, a radiology and psychiatry and behavioral services instructor, are working on solutions to alleviate the added stress for many people who are now being asked to work from home while balancing family life.

Paredes and his collaborators are developing web-based tools specifically a Google Chrome extension and mobile app to support healthy routines for productivity, reduce over-consumption of stressful media and web content, and encourage work-life balance and family interaction.

The project, called Home Sweet Office (HSO), integrates mental health and stress management interventions created in Paredess lab, the Pervasive Wellbeing Technology Lab, with a former project from the lab of Michael Bernstein, associate professor of computer science.

We believe the new normal of human-human interaction will demand new ways of thinking and new tools for productivity, stress and mental health, Paredes said.

HSO aims not only to create tools to increase mental health and stress management, but also aggregate critical data for the future.

The data generated will serve towards studying the longitudinal causal relationships between stress, productivity, and mental health, Paredes said.

Contact Yash Pershad at ypershad at stanford.edu.

Here is the original post:
Stanford researchers tackle COVID-19 from all angles - The Stanford Daily

How COVID-19 is Impacting the Industrial Bioprocessing Market by Industry Analysis, by Type, Application and Top Players:BD Biosciences, BioPharm…

Note: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Industrial BioprocessingMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Industrial Bioprocessing Market Players to battle Covid-19 Impact.

The Industrial BioprocessingMarket report is compilation of intelligent, broad research studies that will help players and stakeholders to make informed business decisions in future. It offers detailed research and analysis of key aspects of the Industrial Bioprocessing market. Readers will be able to gain deeper understanding of the competitive landscape and its future scenarios, crucial dynamics, and leading segments of the global Industrial Bioprocessing market. Buyers of the report will have access to accurate PESTLE, SWOT and other types of analysis on the global Industrial Bioprocessing market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Industrial Bioprocessing markets to extend their reach and create sales opportunities.

The study encompasses profiles of major Companies/Manufacturers operating in the global Industrial Bioprocessing Market.Key players profiled in the report include:BD Biosciences, BioPharm International, GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius Stedim Biotech, Merck Millipore, 3M Company, Eppendorf AG, Finesse Solutions, Applikon Biotechnology B.V., Cesco Bioengineering and More

Get PDF Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, List of Tables & Figures, Chart):https://www.marketinforeports.com/Market-Reports/Request-Sample/145292

Segmental Analysis:The report has classified the global Industrial Bioprocessing market into segments including product type and application. Every segment is evaluated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the Industrial Bioprocessing manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, there by helping market players to gain deep insights into the overall Industrial Bioprocessing industry.

Key Types:Upstream BioprocessingDownstream Bioprocessing

Key End-Use:FoodMedicalPharmaceuticals and NutraceuticalsChemicalsFuelsOthers

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketinforeports.com/Market-Reports/Request_discount/145292

The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the global Industrial Bioprocessing market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Industrial Bioprocessing industry to help players plan effective expansion strategies.

Regions Covered in the Global Industrial Bioprocessing Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2025

For More Information:https://www.marketinforeports.com/Market-Reports/145292/Industrial-Bioprocessing-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/145292/Industrial-Bioprocessing-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: [emailprotected]Website: http://www.marketinforeports.com

See the rest here:
How COVID-19 is Impacting the Industrial Bioprocessing Market by Industry Analysis, by Type, Application and Top Players:BD Biosciences, BioPharm...